Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2a,Condition 2b,Condition 3a,Condition 3b
522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000324,FHH-Chr 15BN/Mcwi,male,84 days to 70 days,8,,CMO:0000725,logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50),,,,-6.9319,,0.05,0.1413,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),55598,phenylephrine (1 umol/l) (for 0.2 hours),acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours),,
522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000324,FHH-Chr 15BN/Mcwi,female,84 days to 70 days,8,,CMO:0000725,logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50),,,,-7.206,,0.0903,0.2553,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),55617,phenylephrine (1 umol/l) (for 0.2 hours),acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours),,
522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000324,FHH-Chr 15BN/Mcwi,male,84 days to 70 days,7,,CMO:0000725,logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50),,,,-6.9879,,0.0881,0.2332,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),56888,controlled sodium content diet (4 %) (for 21 days),phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours)
522,PhysGen Vascular data,vasodilation trait,Moms and pups used in studies were fed Teklad,RS:0000324,FHH-Chr 15BN/Mcwi,female,84 days to 70 days,9,,CMO:0000725,logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50),,,,-7.0707,,0.0667,0.2,MMO:0000208,wire myography using a Digi-Med tissue force analysis system with force transducer,,,,,,,controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours),56907,controlled sodium content diet (4 %) (for 21 days),phenylephrine (1 umol/l) (for 0.2 hours),,acetylcholine (0-30 umol/l) ,drug dose time series (for 1 hours)